Novel Diagnostic Approaches and Treatment of Angina and Myocardial Ischemia
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 194
Special Issue Editors
Interests: percutaneous coronary intervention; interventional cardiology; myocardial infarction; experimental cardiology; cardiac surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
For years, angina and myocardial ischemia were primarily linked with obstructive coronary artery disease. Recent years have revealed evidence that up to 80% of patients experience angina and detectable demand ischemia, despite non-significant coronary artery narrowing. This has led to reconsideration of and focus on the critical role of coronary microcirculation dysfunction (CMD) in the pathophysiology of angina and ischemia with non-obstructive coronary arteries (ANOCA and INOCA). Moreover, despite advances in revascularization and pharmacological treatment, up to 24% of patients with chronic coronary syndrome may suffer from refractory angina.
The recently published 2024 ESC Guidelines for the management of chronic coronary syndromes underline the role of both non-invasive diagnostic approaches for suspected coronary artery disease and appropriate diagnosis of ANOCA and INOCA endotype, upgrading recommendations for invasive testing from class IIb and IIa to class I. Despite the emphasis on coronary microcirculation testing, the strongest evidence available to date comprises small randomized studies and observational reports. Even less data are available for non-invasive diagnostic methods, which include echocardiography, perfusion coronary computed tomography angiography, and cardiac magnetic resonance.
Lifestyle changes and risk factor modification are the cornerstones of chronic coronary syndrome treatment. In patients with CMD, pharmacological approach is either empirical or should be based on a specific endotype after invasive testing. Frequently used drugs include beta-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, and other agents such as ranolazine or trimetazidine, used in monotherapy or combination. Novel invasive therapies for refractory angina include reducer devices for coronary sinus constriction.
The goal of the current issue is to explore epidemiology, novel diagnostic approaches, and particular groups and treatments of angina and myocardial ischemia, including ANOCA and INOCA. Through a collection of original research articles, reviews, and case reports and series, we aim to provide a comprehensive overview of this emerging topic, investigate unmet needs, and uncover future directions in this rapidly evolving field.
Dr. Marcin Kozuch
Guest Editor
Dr. Emil Julian Dąbrowski
Guest Editor Assitant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ischemia
- angina
- chronic coronary syndromes
- ANOCA
- INOCA
- CMD
- CFR
- microcirculation
- scintigraphy
- CMR
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
